More on reports of esophageal cancer with oral bisphosphonate use.
Shaheen
Nicholas J
NJ
D019386:Alendronate / Q000009:adverse effects*; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D035061:Control Groups; D004164:Diphosphonates / Q000009:adverse effects*; D004938:Esophageal Neoplasms / Q000139:chemically induced*; D004941:Esophagitis / Q000139:chemically induced; D006801:Humans
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D019386:Alendronate